Cohance Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	596.6	854	472.3	648.03	445.64
Short-Term Investments	2,663	-	-	-	-
Trading Asset Securities	-	1,917	7,739	4,189	4,812
Cash & Short-Term Investments	3,260	2,771	8,211	4,837	5,258
Cash Growth	17.62%	-66.25%	69.75%	-8.00%	180.01%
Accounts Receivable	6,810	2,844	1,337	1,109	2,364
Other Receivables	19	885.1	562.3	665.92	480.04
Receivables	6,909	3,733	1,907	1,777	2,846
Inventory	5,622	1,729	2,332	3,306	3,000
Prepaid Expenses	-	104.4	49.2	86.28	64
Other Current Assets	2,489	547.3	32.7	103.79	111.67
Total Current Assets	18,280	8,886	12,532	10,110	11,279
Property, Plant & Equipment	21,633	12,500	7,868	7,662	5,620
Long-Term Investments	2,622	1,450	1,306	1,171	1,171
Goodwill	12,837	6,551	602.5	602.58	-
Other Intangible Assets	995.2	638.9	16.8	19.32	22.36
Long-Term Deferred Tax Assets	26.4	5.5	8.1	-	-
Other Long-Term Assets	890.6	240.8	216	91.64	203.02
Total Assets	57,296	30,318	22,549	19,657	18,296
Accounts Payable	2,846	802.1	423.5	700.92	1,059
Accrued Expenses	472.9	1,415	256.9	128.17	266
Short-Term Debt	-	700	385.8	445.98	471.33
Current Portion of Long-Term Debt	1,192	18.9	-	200	200
Current Portion of Leases	252.5	314.5	51.9	4.79	10.91
Current Income Taxes Payable	164.4	11	-	2.94	36.42
Current Unearned Revenue	-	21.6	6.9	8.08	-
Other Current Liabilities	1,532	369.3	49	96.79	59.27
Total Current Liabilities	6,459	3,652	1,174	1,588	2,103
Long-Term Debt	504.8	62.4	-	45.64	284.4
Long-Term Leases	2,056	1,695	212.4	7	4.63
Pension & Post-Retirement Benefits	-	2.6	-	-	11.09
Long-Term Deferred Tax Liabilities	979	909.8	656	582.35	543.15
Other Long-Term Liabilities	6,959	5,590	-	82.95	77.85
Total Liabilities	16,958	11,911	2,042	2,306	3,024
Common Stock	382.6	254.6	254.6	254.57	254.57
Additional Paid-In Capital	-	1,096	1,096	1,096	1,096
Retained Earnings	-	15,083	18,894	15,894	13,820
Comprehensive Income & Other	38,730	532.8	262.3	107.17	101.65
Total Common Equity	39,113	16,966	20,507	17,352	15,272
Minority Interest	1,225	1,441	-	-	-
Shareholders' Equity	40,338	18,406	20,507	17,352	15,272
Total Liabilities & Equity	57,296	30,318	22,549	19,657	18,296
Total Debt	4,005	2,791	650.1	703.41	971.27
Net Cash (Debt)	-745.1	-19.3	7,561	4,134	4,287
Net Cash Growth	-	-	82.90%	-3.56%	858.10%
Net Cash Per Share	-1.95	-0.08	29.70	16.24	16.84
Filing Date Shares Outstanding	383.33	382.57	254.56	254.56	254.56
Total Common Shares Outstanding	383.33	254.56	254.56	254.56	254.56
Working Capital	11,820	5,234	11,358	8,523	9,176
Book Value Per Share	102.03	66.65	80.56	68.16	59.99
Tangible Book Value	25,281	9,776	19,887	16,730	15,249
Tangible Book Value Per Share	65.95	38.40	78.12	65.72	59.90
Land	-	307.8	150.5	150.46	150.46
Buildings	-	2,341	2,206	2,200	1,813
Machinery	-	8,108	5,797	5,410	4,750
Construction In Progress	-	2,548	1,790	1,651	299.94
Leasehold Improvements	-	117.7	42.6	-	-